Brief: Atea Pharmaceuticals posts Q1 net income USD -35.467 million
08/05/2023 21:07
May 8 (Reuters) - Atea Pharmaceuticals Q1 pretax profit USD -35.27 million. * Q1 operating expenses USD 41.569 million * Q1 net income USD -35.467 million
Recent news on Atea Pharmaceuticals
See all newsAtea Pharmaceuticals Q2 loss narrows as HCV trial expenses decline
Atea Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary
Atea Pharmaceuticals, Inc. expected to post a loss of 56 cents a share - Earnings Preview
Atea Pharmaceuticals, Inc. expected to post a loss of 56 cents a share - Earnings Preview
NASDAQ RESUMED AT 07:30 AM